Recent studies performed by Analycen and The Center for Clinical Studies in Uppsala strongly suggests that the activation process to the barley is so mild that the molecule properties remains high and this in it's turn could lead to the conclusion that the Activated Barley has a real impact on the cholesterol effect on humans.

The company are therefore now in the process of finding the external financial resources to conduct a clinical study on humans during the fall/winter, 2004/2005.